Dextromethorphan Hbr-Pyrilamine Maleate
Over-the-Counter상품명: BRONCOCHEM MAXIMUM COUGH NIGHT
About This Medication
Oral preparation used for symptom management and health support.
유효 성분
| 성분 | 함량 |
|---|---|
| Dextromethorphan Hydrobromide | - |
| Pyrilamine Maleate | - |
적응증 및 용법
용량 및 투여 방법
경고 및 주의 사항
Warnings The following side effects may occur, nausea, vomiting, dizziness, headache, or nervousness may occur, if any of these effects last or worsen, contact your doctor or pharmacist immediately. Stop using this medicine and tell your doctor right away if you have dizziness, nervousness, or trouble sleeping.
Frequently Asked Questions
Uses Temporarily relieves these symptoms in all formsof acute, subacute, and cronical cough of any origin, it is very effective in colds, rhinitis, pharyngitis, laryngitis, dry cough, smokers cough, ashma, nervous cough.
Dosage and Administration Do not exceed 4 doses in a 24 hour period. Adult and children 12 years and older: (5 or 10 mL) 3 times a day. Children between 6 to 12 years old: (2.5 mL) 3 times a day.
Warnings The following side effects may occur, nausea, vomiting, dizziness, headache, or nervousness may occur, if any of these effects last or worsen, contact your doctor or pharmacist immediately. Stop using this medicine and tell your doctor right away if you have dizziness, nervousness, or trouble sleeping.
Dextromethorphan Hbr-Pyrilamine Maleate is available over the counter (OTC) without a prescription.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Dextromethorphan Hbr-Pyrilamine Maleate drug label (National Library of Medicine)
- • openFDA — Dextromethorphan Hbr-Pyrilamine Maleate label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 2679777 (NLM Normalized Drug Names)
- • NDC Directory — Dextromethorphan Hbr-Pyrilamine Maleate (FDA National Drug Code)
의료 면책 조항
이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.
의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.
데이터 출처: DailyMed (NLM), openFDA, MFDS